Mark Christopher Capone Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Mark Christopher Capone.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Mark Christopher Capone. Mark Christopher Capone is Chief Operating Officer, MGL in MYRIAD GENETICS INC ($MYGN) and President & C.E.O. in MYRIAD GENETICS INC ($MYGN) and President, MGL in MYRIAD GENETICS INC ($MYGN).
Latest Insider Trading Transactions of Mark Christopher Capone
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Oct 01 2019 | MYGN | MYRIAD GENETICS IN ... | Capone Mark Christopher | President & C.E.O. | Sell | D | 28.63 | 18,295 | 523,786 | 522,216 | 540.5 K to 522.2 K (-3.38 %) |
| Oct 01 2019 | MYGN | MYRIAD GENETICS IN ... | Capone Mark Christopher | President & C.E.O. | Sell | D | 28.63 | 8,727 | 249,854 | 540,511 | 549.2 K to 540.5 K (-1.59 %) |
| Sep 26 2019 | MYGN | MYRIAD GENETICS IN ... | Capone Mark Christopher | President & C.E.O. | Sell | D | 29.93 | 18,295 | 547,569 | 549,238 | 567.5 K to 549.2 K (-3.22 %) |
| Sep 26 2019 | MYGN | MYRIAD GENETICS IN ... | Capone Mark Christopher | President & C.E.O. | Sell | D | 29.93 | 15,800 | 472,894 | 567,533 | 583.3 K to 567.5 K (-2.71 %) |
| Sep 26 2019 | MYGN | MYRIAD GENETICS IN ... | Capone Mark Christopher | President & C.E.O. | Grant | A | 0.00 | 142,500 | 0 | 583,333 | 440.8 K to 583.3 K (+32.33 %) |
| Aug 02 2019 | MYGN | MYRIAD GENETICS IN ... | Capone Mark Christopher | President & C.E.O. | Option Exercise | M | 30.34 | 58,138 | 1,763,907 | 0 | |
| Aug 02 2019 | MYGN | MYRIAD GENETICS IN ... | Capone Mark Christopher | President & C.E.O. | Option Exercise | M | 23.11 | 70,672 | 1,633,230 | 0 | |
| Aug 02 2019 | MYGN | MYRIAD GENETICS IN ... | Capone Mark Christopher | President & C.E.O. | Option Exercise | M | 30.34 | 3,862 | 117,173 | 0 | |
| Aug 02 2019 | MYGN | MYRIAD GENETICS IN ... | Capone Mark Christopher | President & C.E.O. | Option Exercise | M | 23.11 | 4,328 | 100,020 | 0 | |
| Aug 02 2019 | MYGN | MYRIAD GENETICS IN ... | Capone Mark Christopher | President & C.E.O. | Sell | S | 44.00 | 3,862 | 169,928 | 440,833 | 444.7 K to 440.8 K (-0.87 %) |
| Aug 02 2019 | MYGN | MYRIAD GENETICS IN ... | Capone Mark Christopher | President & C.E.O. | Buy | M | 30.34 | 3,862 | 117,173 | 444,695 | 440.8 K to 444.7 K (+0.88 %) |
| Aug 02 2019 | MYGN | MYRIAD GENETICS IN ... | Capone Mark Christopher | President & C.E.O. | Sell | S | 44.00 | 58,138 | 2,558,072 | 440,833 | 499 K to 440.8 K (-11.65 %) |
| Aug 02 2019 | MYGN | MYRIAD GENETICS IN ... | Capone Mark Christopher | President & C.E.O. | Buy | M | 30.34 | 58,138 | 1,763,907 | 498,971 | 440.8 K to 499 K (+13.19 %) |
| Aug 02 2019 | MYGN | MYRIAD GENETICS IN ... | Capone Mark Christopher | President & C.E.O. | Sell | S | 44.00 | 4,328 | 190,432 | 440,833 | 445.2 K to 440.8 K (-0.97 %) |
| Aug 02 2019 | MYGN | MYRIAD GENETICS IN ... | Capone Mark Christopher | President & C.E.O. | Buy | M | 23.11 | 4,328 | 100,020 | 445,161 | 440.8 K to 445.2 K (+0.98 %) |
| Aug 02 2019 | MYGN | MYRIAD GENETICS IN ... | Capone Mark Christopher | President & C.E.O. | Sell | S | 44.00 | 70,672 | 3,109,568 | 440,833 | 511.5 K to 440.8 K (-13.82 %) |
| Aug 02 2019 | MYGN | MYRIAD GENETICS IN ... | Capone Mark Christopher | President & C.E.O. | Buy | M | 23.11 | 70,672 | 1,633,230 | 511,505 | 440.8 K to 511.5 K (+16.03 %) |
| Oct 02 2018 | MYGN | MYRIAD GENETICS IN ... | Capone Mark Christopher | President & C.E.O. | Sell | D | 46.00 | 8,727 | 401,442 | 440,833 | 449.6 K to 440.8 K (-1.94 %) |
| Oct 02 2018 | MYGN | MYRIAD GENETICS IN ... | Capone Mark Christopher | President & C.E.O. | Sell | D | 46.00 | 18,295 | 841,570 | 449,560 | 467.9 K to 449.6 K (-3.91 %) |
| Sep 26 2018 | MYGN | MYRIAD GENETICS IN ... | Capone Mark Christopher | President & C.E.O. | Sell | D | 46.65 | 18,295 | 853,462 | 467,855 | 486.2 K to 467.9 K (-3.76 %) |
| Sep 21 2018 | MYGN | MYRIAD GENETICS IN ... | Capone Mark Christopher | President & C.E.O. | Grant | A | 0.00 | 165,000 | 0 | 486,150 | 321.2 K to 486.2 K (+51.38 %) |
| Sep 18 2018 | MYGN | MYRIAD GENETICS IN ... | Capone Mark Christopher | President & C.E.O. | Sell | D | 46.35 | 11,025 | 511,009 | 321,150 | 332.2 K to 321.2 K (-3.32 %) |
| Jul 13 2018 | MYGN | MYRIAD GENETICS IN ... | Capone Mark Christopher | President & C.E.O. | Option Exercise | M | 30.12 | 77,654 | 2,338,938 | 0 | |
| Jul 13 2018 | MYGN | MYRIAD GENETICS IN ... | Capone Mark Christopher | President & C.E.O. | Option Exercise | M | 30.12 | 2,346 | 70,662 | 0 | |
| Jul 13 2018 | MYGN | MYRIAD GENETICS IN ... | Capone Mark Christopher | President & C.E.O. | Sell | S | 41.00 | 2,346 | 96,186 | 332,175 | 334.5 K to 332.2 K (-0.70 %) |
| Jul 13 2018 | MYGN | MYRIAD GENETICS IN ... | Capone Mark Christopher | President & C.E.O. | Buy | M | 30.12 | 2,346 | 70,662 | 334,521 | 332.2 K to 334.5 K (+0.71 %) |
| Jul 13 2018 | MYGN | MYRIAD GENETICS IN ... | Capone Mark Christopher | President & C.E.O. | Sell | S | 41.00 | 77,654 | 3,183,814 | 332,175 | 409.8 K to 332.2 K (-18.95 %) |
| Jul 13 2018 | MYGN | MYRIAD GENETICS IN ... | Capone Mark Christopher | President & C.E.O. | Buy | M | 30.12 | 77,654 | 2,338,938 | 409,829 | 332.2 K to 409.8 K (+23.38 %) |
| Jun 01 2018 | MYGN | MYRIAD GENETICS IN ... | Capone Mark Christopher | President & C.E.O. | Option Exercise | M | 22.93 | 90,000 | 2,063,700 | 0 | |
| Jun 01 2018 | MYGN | MYRIAD GENETICS IN ... | Capone Mark Christopher | President & C.E.O. | Sell | S | 38.00 | 90,000 | 3,420,000 | 332,175 | 422.2 K to 332.2 K (-21.32 %) |
| Jun 01 2018 | MYGN | MYRIAD GENETICS IN ... | Capone Mark Christopher | President & C.E.O. | Buy | M | 22.93 | 90,000 | 2,063,700 | 422,175 | 332.2 K to 422.2 K (+27.09 %) |
| Oct 03 2017 | MYGN | MYRIAD GENETICS IN ... | Capone Mark Christopher | President & C.E.O. | Sell | D | 36.18 | 9,238 | 334,231 | 332,175 | 341.4 K to 332.2 K (-2.71 %) |
| Oct 03 2017 | MYGN | MYRIAD GENETICS IN ... | Capone Mark Christopher | President & C.E.O. | Sell | D | 36.18 | 19,367 | 700,698 | 341,413 | 360.8 K to 341.4 K (-5.37 %) |
| Sep 19 2017 | MYGN | MYRIAD GENETICS IN ... | Capone Mark Christopher | President & C.E.O. | Sell | D | 33.05 | 11,671 | 385,727 | 360,780 | 372.5 K to 360.8 K (-3.13 %) |
| Sep 15 2017 | MYGN | MYRIAD GENETICS IN ... | Capone Mark Christopher | President & C.E.O. | Grant | A | 0.00 | 165,000 | 0 | 372,451 | 207.5 K to 372.5 K (+79.54 %) |
| Oct 03 2016 | MYGN | MYRIAD GENETICS IN ... | Capone Mark Christopher | President & C.E.O. | Sell | D | 20.58 | 9,238 | 190,118 | 207,451 | 216.7 K to 207.5 K (-4.26 %) |
| Sep 20 2016 | MYGN | MYRIAD GENETICS IN ... | Capone Mark Christopher | President & C.E.O. | Sell | D | 20.92 | 8,042 | 168,239 | 216,689 | 224.7 K to 216.7 K (-3.58 %) |
| Sep 16 2016 | MYGN | MYRIAD GENETICS IN ... | Capone Mark Christopher | President & C.E.O. | Grant | A | 0.00 | 78,705 | 0 | 224,731 | 146 K to 224.7 K (+53.90 %) |
| Aug 19 2016 | MYGN | MYRIAD GENETICS IN ... | Capone Mark Christopher | President & C.E.O. | Buy | P | 21.24 | 10,000 | 212,400 | 146,026 | 136 K to 146 K (+7.35 %) |
| Sep 17 2015 | MYGN | MYRIAD GENETICS IN ... | Capone Mark Christopher | President & C.E.O. | Payment of Exercise | F | 41.39 | 11,671 | 483,063 | 136,026 | 147.7 K to 136 K (-7.90 %) |
| Aug 14 2015 | MYGN | MYRIAD GENETICS IN ... | Capone Mark Christopher | President & C.E.O. | Grant | A | 0.00 | 99,429 | 0 | 147,697 | 48.3 K to 147.7 K (+205.99 %) |
| Feb 25 2014 | MYGN | MYRIAD GENETICS IN ... | Capone Mark Christopher | President, MGL | Option Exercise | M | 19.47 | 64,000 | 1,246,080 | 144,000 | |
| Feb 25 2014 | MYGN | MYRIAD GENETICS IN ... | Capone Mark Christopher | President, MGL | Option Exercise | M | 18.00 | 31,250 | 562,500 | 25,695 | |
| Feb 25 2014 | MYGN | MYRIAD GENETICS IN ... | Capone Mark Christopher | President, MGL | Sell | S | 37.83 | 31,250 | 1,182,188 | 48,268 | 79.5 K to 48.3 K (-39.30 %) |
| Feb 25 2014 | MYGN | MYRIAD GENETICS IN ... | Capone Mark Christopher | President, MGL | Buy | M | 18.00 | 31,250 | 562,500 | 79,518 | 48.3 K to 79.5 K (+64.74 %) |
| Feb 25 2014 | MYGN | MYRIAD GENETICS IN ... | Capone Mark Christopher | President, MGL | Sell | S | 37.83 | 64,000 | 2,421,120 | 48,268 | 112.3 K to 48.3 K (-57.01 %) |
| Feb 25 2014 | MYGN | MYRIAD GENETICS IN ... | Capone Mark Christopher | President, MGL | Buy | M | 19.47 | 64,000 | 1,246,080 | 112,268 | 48.3 K to 112.3 K (+132.59 %) |
| Feb 10 2014 | MYGN | MYRIAD GENETICS IN ... | Capone Mark Christopher | President, MGL | Option Exercise | M | 18.00 | 62,500 | 1,125,000 | 56,945 | |
| Feb 10 2014 | MYGN | MYRIAD GENETICS IN ... | Capone Mark Christopher | President, MGL | Option Exercise | M | 16.53 | 25,000 | 413,250 | 25,000 | |
| Feb 10 2014 | MYGN | MYRIAD GENETICS IN ... | Capone Mark Christopher | President, MGL | Sell | S | 32.07 | 62,500 | 2,004,225 | 48,268 | 110.8 K to 48.3 K (-56.42 %) |
| Feb 10 2014 | MYGN | MYRIAD GENETICS IN ... | Capone Mark Christopher | President, MGL | Buy | M | 18.00 | 62,500 | 1,125,000 | 110,768 | 48.3 K to 110.8 K (+129.49 %) |
| Feb 10 2014 | MYGN | MYRIAD GENETICS IN ... | Capone Mark Christopher | President, MGL | Sell | S | 32.07 | 25,000 | 801,690 | 48,268 | 73.3 K to 48.3 K (-34.12 %) |
| Feb 10 2014 | MYGN | MYRIAD GENETICS IN ... | Capone Mark Christopher | President, MGL | Buy | M | 16.53 | 25,000 | 413,250 | 73,268 | 48.3 K to 73.3 K (+51.79 %) |
| Sep 19 2013 | MYGN | MYRIAD GENETICS IN ... | Capone Mark Christopher | President, MGL | Option Exercise | A | 26.49 | 326,225 | 8,641,700 | 326,225 | |
| Sep 19 2013 | MYGN | MYRIAD GENETICS IN ... | Capone Mark Christopher | President, MGL | Option Exercise | A | 26.49 | 3,775 | 100,000 | 3,775 | |
| May 17 2013 | MYGN | MYRIAD GENETICS IN ... | Capone Mark Christopher | President, MGL | Option Exercise | M | 18.06 | 60,000 | 1,083,600 | 0 | |
| May 17 2013 | MYGN | MYRIAD GENETICS IN ... | Capone Mark Christopher | President, MGL | Option Exercise | M | 16.53 | 19,999 | 330,583 | 50,000 | |
| May 17 2013 | MYGN | MYRIAD GENETICS IN ... | Capone Mark Christopher | President, MGL | Sell | S | 33.23 | 19,999 | 664,603 | 48,268 | 68.3 K to 48.3 K (-29.30 %) |
| May 17 2013 | MYGN | MYRIAD GENETICS IN ... | Capone Mark Christopher | President, MGL | Buy | M | 16.53 | 19,999 | 330,583 | 68,267 | 48.3 K to 68.3 K (+41.43 %) |
| May 17 2013 | MYGN | MYRIAD GENETICS IN ... | Capone Mark Christopher | President, MGL | Sell | S | 33.23 | 60,000 | 1,993,908 | 48,268 | 108.3 K to 48.3 K (-55.42 %) |
| May 17 2013 | MYGN | MYRIAD GENETICS IN ... | Capone Mark Christopher | President, MGL | Buy | M | 18.06 | 60,000 | 1,083,600 | 108,268 | 48.3 K to 108.3 K (+124.31 %) |
| Nov 21 2012 | MYGN | MYRIAD GENETICS IN ... | Capone Mark Christopher | President, MGL | Option Exercise | M | 16.53 | 314 | 5,190 | 69,999 | |
| Nov 21 2012 | MYGN | MYRIAD GENETICS IN ... | Capone Mark Christopher | President, MGL | Option Exercise | M | 16.53 | 29,686 | 490,710 | 70,313 | |
| Nov 21 2012 | MYGN | MYRIAD GENETICS IN ... | Capone Mark Christopher | President, MGL | Option Exercise | M | 13.28 | 5,324 | 70,703 | 0 | |
| Nov 21 2012 | MYGN | MYRIAD GENETICS IN ... | Capone Mark Christopher | President, MGL | Sell | S | 30.03 | 314 | 9,431 | 48,268 | 48.6 K to 48.3 K (-0.65 %) |
| Nov 21 2012 | MYGN | MYRIAD GENETICS IN ... | Capone Mark Christopher | President, MGL | Buy | M | 16.53 | 314 | 5,190 | 48,582 | 48.3 K to 48.6 K (+0.65 %) |
| Nov 21 2012 | MYGN | MYRIAD GENETICS IN ... | Capone Mark Christopher | President, MGL | Sell | S | 30.41 | 29,686 | 902,751 | 48,268 | 78 K to 48.3 K (-38.08 %) |
| Nov 21 2012 | MYGN | MYRIAD GENETICS IN ... | Capone Mark Christopher | President, MGL | Buy | M | 16.53 | 29,686 | 490,710 | 77,954 | 48.3 K to 78 K (+61.50 %) |
| Nov 21 2012 | MYGN | MYRIAD GENETICS IN ... | Capone Mark Christopher | President, MGL | Sell | S | 30.41 | 5,324 | 161,903 | 48,268 | 53.6 K to 48.3 K (-9.93 %) |
| Nov 21 2012 | MYGN | MYRIAD GENETICS IN ... | Capone Mark Christopher | President, MGL | Buy | M | 13.28 | 5,324 | 70,703 | 53,592 | 48.3 K to 53.6 K (+11.03 %) |
| Nov 08 2012 | MYGN | MYRIAD GENETICS IN ... | Capone Mark Christopher | President, MGL | Option Exercise | M | 12.17 | 21,192 | 257,907 | 0 | |
| Nov 08 2012 | MYGN | MYRIAD GENETICS IN ... | Capone Mark Christopher | President, MGL | Option Exercise | M | 12.17 | 5,808 | 70,683 | 0 | |
| Nov 08 2012 | MYGN | MYRIAD GENETICS IN ... | Capone Mark Christopher | President, MGL | Sell | S | 28.75 | 21,192 | 609,270 | 48,268 | 69.5 K to 48.3 K (-30.51 %) |
| Nov 08 2012 | MYGN | MYRIAD GENETICS IN ... | Capone Mark Christopher | President, MGL | Buy | M | 12.17 | 21,192 | 257,907 | 69,460 | 48.3 K to 69.5 K (+43.90 %) |
| Nov 08 2012 | MYGN | MYRIAD GENETICS IN ... | Capone Mark Christopher | President, MGL | Sell | S | 28.75 | 5,808 | 166,980 | 48,268 | 54.1 K to 48.3 K (-10.74 %) |
| Nov 08 2012 | MYGN | MYRIAD GENETICS IN ... | Capone Mark Christopher | President, MGL | Buy | M | 12.17 | 5,808 | 70,683 | 54,076 | 48.3 K to 54.1 K (+12.03 %) |
| Nov 08 2012 | MYGN | MYRIAD GENETICS IN ... | Capone Mark Christopher | President, MGL | Gift | G | 0.00 | 1,000 | 0 | 48,268 | 49.3 K to 48.3 K (-2.03 %) |
| Nov 13 2012 | MYGN | MYRIAD GENETICS IN ... | Capone Mark Christopher | President, MGL | Option Exercise | M | 13.28 | 62,176 | 825,697 | 0 | |
| Nov 13 2012 | MYGN | MYRIAD GENETICS IN ... | Capone Mark Christopher | President, MGL | Sell | S | 29.91 | 62,176 | 1,859,796 | 48,268 | 110.4 K to 48.3 K (-56.30 %) |
| Nov 13 2012 | MYGN | MYRIAD GENETICS IN ... | Capone Mark Christopher | President, MGL | Buy | M | 13.28 | 62,176 | 825,697 | 110,444 | 48.3 K to 110.4 K (+128.81 %) |
| Sep 14 2012 | MYGN | MYRIAD GENETICS IN ... | Capone Mark Christopher | President, MGL | Option Exercise | A | 27.07 | 300,000 | 8,121,000 | 300,000 | |
| Sep 12 2012 | MYGN | MYRIAD GENETICS IN ... | Capone Mark Christopher | President, MGL | Option Exercise | M | 9.04 | 14,104 | 127,500 | 0 | |
| Sep 12 2012 | MYGN | MYRIAD GENETICS IN ... | Capone Mark Christopher | President, MGL | Option Exercise | M | 9.04 | 1,251 | 11,309 | 0 | |
| Sep 12 2012 | MYGN | MYRIAD GENETICS IN ... | Capone Mark Christopher | President, MGL | Option Exercise | M | 8.63 | 4,450 | 38,404 | 0 | |
| Sep 12 2012 | MYGN | MYRIAD GENETICS IN ... | Capone Mark Christopher | President, MGL | Sell | S | 27.00 | 14,104 | 380,808 | 49,268 | 63.4 K to 49.3 K (-22.26 %) |
| Sep 12 2012 | MYGN | MYRIAD GENETICS IN ... | Capone Mark Christopher | President, MGL | Buy | M | 9.04 | 14,104 | 127,500 | 63,372 | 49.3 K to 63.4 K (+28.63 %) |
| Sep 12 2012 | MYGN | MYRIAD GENETICS IN ... | Capone Mark Christopher | President, MGL | Sell | S | 27.00 | 1,251 | 33,777 | 49,268 | 50.5 K to 49.3 K (-2.48 %) |
| Sep 12 2012 | MYGN | MYRIAD GENETICS IN ... | Capone Mark Christopher | President, MGL | Buy | M | 9.04 | 1,251 | 11,309 | 50,519 | 49.3 K to 50.5 K (+2.54 %) |
| Sep 12 2012 | MYGN | MYRIAD GENETICS IN ... | Capone Mark Christopher | President, MGL | Sell | S | 27.00 | 4,450 | 120,150 | 49,268 | 53.7 K to 49.3 K (-8.28 %) |
| Sep 12 2012 | MYGN | MYRIAD GENETICS IN ... | Capone Mark Christopher | President, MGL | Buy | M | 8.63 | 4,450 | 38,404 | 53,718 | 49.3 K to 53.7 K (+9.03 %) |
| May 04 2012 | MYGN | MYRIAD GENETICS IN ... | Capone Mark Christopher | President, MGL | Option Exercise | M | 9.04 | 3,707 | 33,511 | 1,251 | |
| May 04 2012 | MYGN | MYRIAD GENETICS IN ... | Capone Mark Christopher | President, MGL | Option Exercise | M | 8.63 | 550 | 4,747 | 4,450 | |
| May 04 2012 | MYGN | MYRIAD GENETICS IN ... | Capone Mark Christopher | President, MGL | Sell | S | 27.00 | 3,707 | 100,089 | 49,268 | 53 K to 49.3 K (-7.00 %) |
| May 04 2012 | MYGN | MYRIAD GENETICS IN ... | Capone Mark Christopher | President, MGL | Buy | M | 9.04 | 3,707 | 33,511 | 52,975 | 49.3 K to 53 K (+7.52 %) |
| May 04 2012 | MYGN | MYRIAD GENETICS IN ... | Capone Mark Christopher | President, MGL | Sell | S | 27.00 | 550 | 14,850 | 49,268 | 49.8 K to 49.3 K (-1.10 %) |
| May 04 2012 | MYGN | MYRIAD GENETICS IN ... | Capone Mark Christopher | President, MGL | Buy | M | 8.63 | 550 | 4,747 | 49,818 | 49.3 K to 49.8 K (+1.12 %) |
| Mar 08 2012 | MYGN | MYRIAD GENETICS IN ... | Capone Mark Christopher | President, MGL | Option Exercise | A | 23.98 | 47,830 | 1,146,963 | 47,830 | |
| Mar 08 2012 | MYGN | MYRIAD GENETICS IN ... | Capone Mark Christopher | President, MGL | Option Exercise | A | 23.98 | 4,170 | 99,997 | 4,170 | |
| Sep 15 2011 | MYGN | MYRIAD GENETICS IN ... | Capone Mark Christopher | President, MGL | Option Exercise | A | 19.47 | 208,000 | 4,049,760 | 208,000 | |
| Feb 24 2011 | MYGN | MYRIAD GENETICS IN ... | Capone Mark Christopher | President, MGL | Option Exercise | A | 18.00 | 119,445 | 2,150,010 | 119,445 | |
| Feb 24 2011 | MYGN | MYRIAD GENETICS IN ... | Capone Mark Christopher | President, MGL | Option Exercise | A | 18.00 | 5,555 | 99,990 | 5,555 | |
| Sep 17 2010 | MYGN | MYRIAD GENETICS IN ... | Capone Mark Christopher | President, MGL | Option Exercise | A | 16.53 | 99,999 | 1,652,983 | 99,999 | |
| Sep 17 2010 | MYGN | MYRIAD GENETICS IN ... | Capone Mark Christopher | President, MGL | Option Exercise | A | 16.53 | 1 | 17 | 1 | |
| Jul 14 2010 | MYGN | MYRIAD GENETICS IN ... | Capone Mark Christopher | President, MGL | Option Exercise | M | 8.63 | 5,000 | 43,150 | 5,000 | |
| Jul 14 2010 | MYGN | MYRIAD GENETICS IN ... | Capone Mark Christopher | President, MGL | Buy | M | 8.63 | 5,000 | 43,150 | 50,268 | 45.3 K to 50.3 K (+11.05 %) |
| May 11 2010 | MYGN | MYRIAD GENETICS IN ... | Capone Mark Christopher | President, MGL | Option Exercise | M | 9.04 | 2,814 | 25,439 | 4,958 | |
| May 11 2010 | MYGN | MYRIAD GENETICS IN ... | Capone Mark Christopher | President, MGL | Buy | M | 9.04 | 2,814 | 25,439 | 45,268 | 42.5 K to 45.3 K (+6.63 %) |
| Mar 05 2010 | MYGN | MYRIAD GENETICS IN ... | Capone Mark Christopher | President, MGL | Option Exercise | A | 23.11 | 70,672 | 1,633,230 | 70,672 | |
| Mar 05 2010 | MYGN | MYRIAD GENETICS IN ... | Capone Mark Christopher | President, MGL | Option Exercise | A | 23.11 | 4,328 | 100,020 | 4,328 | |
| Feb 19 2010 | MYGN | MYRIAD GENETICS IN ... | Capone Mark Christopher | Chief Operating Off ... | Option Exercise | M | 8.63 | 2,000 | 17,260 | 10,000 | |
| Feb 19 2010 | MYGN | MYRIAD GENETICS IN ... | Capone Mark Christopher | Chief Operating Off ... | Option Exercise | M | 7.27 | 5,000 | 36,350 | 20,000 | |
| Feb 19 2010 | MYGN | MYRIAD GENETICS IN ... | Capone Mark Christopher | Chief Operating Off ... | Buy | M | 8.63 | 2,000 | 17,260 | 42,454 | 40.5 K to 42.5 K (+4.94 %) |
| Feb 19 2010 | MYGN | MYRIAD GENETICS IN ... | Capone Mark Christopher | Chief Operating Off ... | Buy | M | 7.27 | 5,000 | 36,350 | 40,454 | 35.5 K to 40.5 K (+14.10 %) |
| Sep 17 2009 | MYGN | MYRIAD GENETICS IN ... | Capone Mark Christopher | Chief Operating Off ... | Option Exercise | A | 30.34 | 58,138 | 1,763,907 | 58,138 | |
| Sep 17 2009 | MYGN | MYRIAD GENETICS IN ... | Capone Mark Christopher | Chief Operating Off ... | Option Exercise | A | 30.34 | 3,862 | 117,173 | 3,862 | |
| Jul 14 2009 | MYGN | MYRIAD GENETICS IN ... | Capone Mark Christopher | Chief Operating Off ... | Option Exercise | M | 7.27 | 15,000 | 109,050 | 5,000 | |
| Jul 14 2009 | MYGN | MYRIAD GENETICS IN ... | Capone Mark Christopher | Chief Operating Off ... | Buy | M | 7.27 | 15,000 | 109,050 | 35,454 | 20.5 K to 35.5 K (+73.34 %) |
| Apr 07 2009 | MYGN | MYRIAD GENETICS IN ... | Capone Mark Christopher | Chief Operating Off ... | Option Exercise | M | 18.78 | 22,500 | 422,550 | 62,176 | |
| Apr 07 2009 | MYGN | MYRIAD GENETICS IN ... | Capone Mark Christopher | Chief Operating Off ... | Option Exercise | M | 17.22 | 13,500 | 232,403 | 21,192 | |
| Apr 07 2009 | MYGN | MYRIAD GENETICS IN ... | Capone Mark Christopher | Chief Operating Off ... | Sell | S | 43.15 | 13,500 | 582,525 | 20,454 | 34 K to 20.5 K (-39.76 %) |
| Apr 07 2009 | MYGN | MYRIAD GENETICS IN ... | Capone Mark Christopher | Chief Operating Off ... | Buy | M | 17.22 | 13,500 | 232,403 | 33,954 | 20.5 K to 34 K (+66.00 %) |
| Apr 07 2009 | MYGN | MYRIAD GENETICS IN ... | Capone Mark Christopher | Chief Operating Off ... | Sell | S | 43.02 | 22,500 | 967,950 | 20,454 | 43 K to 20.5 K (-52.38 %) |
| Apr 07 2009 | MYGN | MYRIAD GENETICS IN ... | Capone Mark Christopher | Chief Operating Off ... | Buy | M | 18.78 | 22,500 | 422,550 | 42,954 | 20.5 K to 43 K (+110.00 %) |
| Feb 24 2009 | MYGN | MYRIAD GENETICS IN ... | Capone Mark Christopher | Chief Operating Off ... | Option Exercise | M | 15.28 | 7,227 | 110,429 | 0 | |
| Feb 24 2009 | MYGN | MYRIAD GENETICS IN ... | Capone Mark Christopher | Chief Operating Off ... | Buy | M | 15.28 | 7,227 | 110,429 | 10,227 | 3 K to 10.2 K (+240.90 %) |
| Feb 20 2009 | MYGN | MYRIAD GENETICS IN ... | Capone Mark Christopher | Chief Operating Off ... | Option Exercise | A | 85.20 | 38,827 | 3,308,060 | 38,827 | |
| Feb 20 2009 | MYGN | MYRIAD GENETICS IN ... | Capone Mark Christopher | Chief Operating Off ... | Option Exercise | A | 85.20 | 1,173 | 99,940 | 1,173 | |
| Feb 11 2009 | MYGN | MYRIAD GENETICS IN ... | Capone Mark Christopher | Chief Operating Off ... | Option Exercise | M | 34.43 | 6,750 | 232,403 | 17,346 | |
| Feb 11 2009 | MYGN | MYRIAD GENETICS IN ... | Capone Mark Christopher | Chief Operating Off ... | Option Exercise | M | 25.57 | 9,062 | 231,715 | 7,052 | |
| Feb 11 2009 | MYGN | MYRIAD GENETICS IN ... | Capone Mark Christopher | Chief Operating Off ... | Sell | S | 85.40 | 6,750 | 576,443 | 3,000 | 9.8 K to 3 K (-69.23 %) |
| Feb 11 2009 | MYGN | MYRIAD GENETICS IN ... | Capone Mark Christopher | Chief Operating Off ... | Buy | M | 34.43 | 6,750 | 232,403 | 9,750 | 3 K to 9.8 K (+225.00 %) |
| Feb 11 2009 | MYGN | MYRIAD GENETICS IN ... | Capone Mark Christopher | Chief Operating Off ... | Sell | S | 85.40 | 9,062 | 773,885 | 3,000 | 12.1 K to 3 K (-75.13 %) |
| Feb 11 2009 | MYGN | MYRIAD GENETICS IN ... | Capone Mark Christopher | Chief Operating Off ... | Buy | M | 25.57 | 9,062 | 231,715 | 12,062 | 3 K to 12.1 K (+302.07 %) |
| Feb 11 2009 | MYGN | MYRIAD GENETICS IN ... | Capone Mark Christopher | Chief Operating Off ... | Sell | S | 85.40 | 6,081 | 519,311 | 3,000 | 9.1 K to 3 K (-66.96 %) |
| Sep 12 2008 | MYGN | MYRIAD GENETICS IN ... | Capone Mark Christopher | Chief Operating Off ... | Option Exercise | A | 64.88 | 45,000 | 2,919,600 | 45,000 | |
| Sep 11 2008 | MYGN | MYRIAD GENETICS IN ... | Capone Mark Christopher | Chief Operating Off ... | Option Exercise | M | 15.28 | 3,000 | 45,840 | 7,227 | |
| Sep 11 2008 | MYGN | MYRIAD GENETICS IN ... | Capone Mark Christopher | Chief Operating Off ... | Buy | M | 15.28 | 3,000 | 45,840 | 9,081 | 6.1 K to 9.1 K (+49.33 %) |
| Sep 03 2008 | MYGN | MYRIAD GENETICS IN ... | Capone Mark Christopher | Chief Operating Off ... | Option Exercise | M | 22.12 | 2,030 | 44,904 | 0 | |
| Sep 03 2008 | MYGN | MYRIAD GENETICS IN ... | Capone Mark Christopher | Chief Operating Off ... | Option Exercise | M | 22.12 | 5,470 | 120,996 | 2,030 | |
| Sep 03 2008 | MYGN | MYRIAD GENETICS IN ... | Capone Mark Christopher | Chief Operating Off ... | Option Exercise | M | 16.97 | 3,000 | 50,910 | 0 | |
| Sep 03 2008 | MYGN | MYRIAD GENETICS IN ... | Capone Mark Christopher | Chief Operating Off ... | Option Exercise | M | 16.64 | 5,184 | 86,262 | 0 | |
| Sep 03 2008 | MYGN | MYRIAD GENETICS IN ... | Capone Mark Christopher | Chief Operating Off ... | Option Exercise | M | 16.64 | 2,316 | 38,538 | 5,184 | |
| Sep 03 2008 | MYGN | MYRIAD GENETICS IN ... | Capone Mark Christopher | Chief Operating Off ... | Sell | S | 67.93 | 2,030 | 137,906 | 6,081 | 8.1 K to 6.1 K (-25.03 %) |
| Sep 03 2008 | MYGN | MYRIAD GENETICS IN ... | Capone Mark Christopher | Chief Operating Off ... | Buy | M | 22.12 | 2,030 | 44,904 | 8,111 | 6.1 K to 8.1 K (+33.38 %) |
| Sep 03 2008 | MYGN | MYRIAD GENETICS IN ... | Capone Mark Christopher | Chief Operating Off ... | Sell | S | 67.93 | 5,184 | 352,170 | 6,081 | 11.3 K to 6.1 K (-46.02 %) |
| Sep 03 2008 | MYGN | MYRIAD GENETICS IN ... | Capone Mark Christopher | Chief Operating Off ... | Buy | M | 16.64 | 5,184 | 86,262 | 11,265 | 6.1 K to 11.3 K (+85.25 %) |
| Sep 03 2008 | MYGN | MYRIAD GENETICS IN ... | Capone Mark Christopher | Chief Operating Off ... | Sell | S | 67.93 | 2,316 | 157,335 | 6,081 | 8.4 K to 6.1 K (-27.58 %) |
| Sep 03 2008 | MYGN | MYRIAD GENETICS IN ... | Capone Mark Christopher | Chief Operating Off ... | Buy | M | 16.64 | 2,316 | 38,538 | 8,397 | 6.1 K to 8.4 K (+38.09 %) |
| Sep 03 2008 | MYGN | MYRIAD GENETICS IN ... | Capone Mark Christopher | Chief Operating Off ... | Sell | S | 67.93 | 3,000 | 203,802 | 6,081 | 9.1 K to 6.1 K (-33.04 %) |
| Sep 03 2008 | MYGN | MYRIAD GENETICS IN ... | Capone Mark Christopher | Chief Operating Off ... | Buy | M | 16.97 | 3,000 | 50,910 | 9,081 | 6.1 K to 9.1 K (+49.33 %) |